Show simple item record

dc.contributor.authorBowie, Andrew
dc.date.accessioned2020-01-15T13:22:39Z
dc.date.available2020-01-15T13:22:39Z
dc.date.issued2019
dc.date.submitted2019en
dc.identifier.citationBowie, A.G., Harnessing poxviral know-how for anti-cytokine therapies, Journal of Biological Chemistry, 294, 13, 2019, 5228-5229en
dc.identifier.otherY
dc.description.abstractPoxviruses have evolved efficient proteins that bind mammalian cytokines and chemokines to suppress host immunity. HerePontejoet al.examine in detail how one such poxviral protein,CrmD, that has activity against both mammalian tumor necrosisfactor and chemokines, interacts with its host targets. Theyapply their findings to refine a human anti-cytokine therapeuticand increase its specificity, providing an elegant example of thebenefits of mining viral proteins for therapeutically useful infor-mationen
dc.format.extent5228-5229en
dc.language.isoenen
dc.relation.ispartofseriesJournal of Biological Chemistry;
dc.relation.ispartofseries294;
dc.relation.ispartofseries13;
dc.rightsYen
dc.subjectPoxvirusesen
dc.subjectBind mammalian cytokines and chemokinesen
dc.subjectMammalian tumor necrosis factoren
dc.titleHarnessing poxviral know-how for anti-cytokine therapiesen
dc.typeJournal Articleen
dc.type.supercollectionscholarly_publicationsen
dc.type.supercollectionrefereed_publicationsen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/agbowie
dc.identifier.rssinternalid206273
dc.identifier.doihttp://dx.doi.org/10.1074/jbc.H119.008151
dc.rights.ecaccessrightsopenAccess
dc.identifier.orcid_id0000-0001-5316-4373
dc.contributor.sponsorScience Foundation Ireland (SFI)en
dc.contributor.sponsorGrantNumber16/IA/4376en
dc.identifier.urihttp://www.jbc.org/content/294/13/5228
dc.identifier.urihttp://hdl.handle.net/2262/91329


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record